Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the most common type of lung cancer and the leading cause of cancer incidence and mortality worldwide. Despite the improvement of traditional and immunological therapies, the clinical outcome of LUAD is still far from satisfactory. Patients given the same treatment regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Tianyu, Lu, Jian, Niu, Delei, Zhang, Yue, Wang, Bin, Zhang, Bei, Zhang, Zugui, He, Xinjiai, Peng, Nan, Li, Biao, Fang, Huilong, Gong, Zheng, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723329/
https://www.ncbi.nlm.nih.gov/pubmed/36483553
http://dx.doi.org/10.3389/fimmu.2022.1046121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723329/
https://www.ncbi.nlm.nih.gov/pubmed/36483553
http://dx.doi.org/10.3389/fimmu.2022.1046121

Ejemplares similares